Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia
Paul Piehowski, Cristina E. Tognon, Camilo Posso, Karl Weitz et al.
Journal
Haematologica
Topics
Lung Cancer Treatments and Mutations
article
Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia
Paul Piehowski, Cristina E. Tognon, Camilo Posso, Karl Weitz, Janét Pittsenbarger, Brian Druker, Nicola Long, Richard D. Press, Sunil K. Joshi, Jeffrey Tyner, Ujwal Shinde, Ariane Huang, Marina Gritsenko, Karin Rodland, Kevin Watanabe‐Smith, Sara J.C. Gosline, Chelsea Hutchinson
article en
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(7)
Institutions
Pacific Northwest National Laboratory (US), Oregon Health & Science University (US), Environmental Molecular Sciences Laboratory (US), Stanford University (US)